Status:
COMPLETED
3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Cairo University
Conditions:
Fibroid
Eligibility:
FEMALE
20-60 years
Brief Summary
• three-dimensional saline infusion sonohysterography (3D SIS) was performed in all cases. A sterile Cuscoe speculum was passed, the cervix visualized and cleaned with sterile chlorhexidine solution. ...
Detailed Description
The speculum was removed and a 5 MHz transvaginal 3D ultrasound probe inserted into the vagina (Voluson 730; KretzTechnik, Austria).
Eligibility Criteria
Inclusion
- • Women between 20 and 60 years with abnormal uterine bleeding in form of heavy menstrual bleeding, irregular and heavy menstrual bleeding) diagnosed on non-enhanced two-dimensional ultrasonography with submucous fibroids.
- Absence of STD, PID, active vaginal bleeding.
Exclusion
- Presence of general cause of abnormal uterine bleeding
- History of drug use that can cause vaginal bleeding (anticoagulants, OCPs, HRT)
- History of recent hormonal treatment
- High risk of undergoing hysteroscopy
- Vaginal, Vulval causes of bleeding
Key Trial Info
Start Date :
February 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 17 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04736095
Start Date
February 7 2021
End Date
May 17 2021
Last Update
May 25 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah
Giza, Egypt
2
Aljazeera( Al Gazeera) hospital
Giza, Egypt